Skip to main navigation Skip to search Skip to main content

Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector

  • Marc van de Wetering
  • , Irma Oving
  • , Vanesa Muncan
  • , Menno Tjon Pon Fong
  • , Helen Brantjes
  • , Dik van Leenen
  • , Frank C.P. Holstege
  • , Thijn R. Brummelkamp
  • , Reuven Agami
  • , Hans Clevers

Research output: Contribution to journalArticlepeer-review

469 Citations (Scopus)

Abstract

We have designed a doxycycline-regulated form of the H1 promoter of RNA polymerase III that allows the inducible knockdown of gene expression by small interfering RNAs (siRNAs). As a proof-of-principle, we have targeted β-catenin in colorectal cancer (CRC) cells. T-cell factor (TCF) target-gene expression is induced by accumulated β-catenin, and is the main transforming event in these cells. We have shown previously that the disruption of β-catenin/TCF4 activity in CRC cells by the overexpression of dominant-negative TCF induces rapid G1 arrest and differentiation. Stable integration of our inducible siRNA vector allowed the rapid production of siRNAs on doxycycline induction, followed by specific downregulation of β-catenin. In these CRC cells, TCF reporter-gene activity was inhibited, and G1 arrest and differentiation occurred. The inhibition of two other genes using this vector system shows that it should be useful for the inducible knockdown of gene expression.

Original languageEnglish
Pages (from-to)609-615
Number of pages7
JournalEMBO Reports
Volume4
Issue number6
DOIs
Publication statusPublished - 1 Jun 2003
Externally publishedYes

Fingerprint

Dive into the research topics of 'Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector'. Together they form a unique fingerprint.

Cite this